The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues

Pharmacological Research

Volumn 54, Issue 5, 2006, Pages 341-344

  Clapper, Jason R ^a   Duranti, Andrea ^c   Tontini, Andrea ^c   Mor, Marco ^b   Tarzia, Giorgio ^c   Piomelli, Daniele ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anandamide; Fatty acid amide hydrolase; Triacylglycerol hydrolase; URB597

Indexed keywords

CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ESTER DERIVATIVE; HORMONE SENSITIVE LIPASE; HYDROLASE INHIBITOR; NANOPARTICLE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRIOLEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; HYDROLYSIS; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RAT;

ADIPOSE TISSUE, WHITE; AMIDOHYDROLASES; ANIMALS; BENZAMIDES; BRAIN; CARBAMATES; ENZYME INHIBITORS; HYDROLYSIS; LIVER; MALE; MYOCARDIUM; RATS; RATS, WISTAR; TRIGLYCERIDES; TRIOLEIN;

EID: 33749655737     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.06.008     Document Type: Article

References (18)

1. Belfrage P., and Vaughan M. Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. J Lipid Res 10 (1969) 341-344
2. Calignano A., La Rana G., Giuffrida A., and Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 394 (1998) 277-281
3. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., and Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384 (1996) 83-87
4. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty-acid amide hydrolase. Proc Natl Acad Sci 98 (2001) 9371-9376
5. Dolinsky V.W., Sipione S., Lehner R., and Vance D.E. The cloning and expression of a murine triacylglycerol hydrolase cDNA and the structure of its corresponding gene. Biochim Biophys Acta 1532 (2001) 162-172
6. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83 (2003) 1017-1066
7. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci 102 (2005) 18620-18625
8. Kathuria S., Gaetani S., Fegley D., Valiño F., Duranti A., Tontini A., et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9 (2003) 76-81
9. Lehner R., and Verger R. Purification and characterization of a porcine liver microsomal triacylglycerol hydrolase. Biochemistry 36 (1997) 1861-1868
10. Leung D., Hardouin C., Boger D.L., and Cravatt B.F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat Biotechnol 21 (2003) 687-691
11. Lichtman A.H., Leung D., Shelton C.C., Saghatelian A., Hardouin C., Boger D.L., et al. Reversible inhibitors of fatty-acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J Pharmacol Exp Ther 311 (2004) 441-448
12. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 46 (2006) 101-122
13. Mor M., Rivara S., Lodola A., Plazzi P.V., Tarzia G., Duranti A., et al. Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty-acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. J Med Chem 47 (2004) 4998-5008
14. Piomelli D. The endocannabinoid system: a drug discovery perspective. Curr Opin Investigating Drugs 6 (2005) 672-679
15. Piomelli D., Tarzia G., Duranti A., Tontini A., Mor M., Compton T.R., et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 12 (2006) 21-38
16. Rodríguez de Fonseca F., Navarro M., Gomez R., Escuredo L., Nava F., Fu J., et al. An anorexic lipid mediator regulated by feeding. Nature 414 (2001) 209-212
17. Tarzia G., Duranti A., Tontini A., Piersanti G., Mor M., Rivara S., et al. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty-acid amide hydrolase inhibitors. J Med Chem 46 (2003) 2352-2360
18. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306 (2004) 1383-1386